Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Min, Su Ji | - |
dc.contributor.author | Lee, Heesu | - |
dc.contributor.author | Shin, Myoung-Sook | - |
dc.contributor.author | Lee, Jae Wook | - |
dc.date.accessioned | 2024-01-19T09:30:44Z | - |
dc.date.available | 2024-01-19T09:30:44Z | - |
dc.date.created | 2023-07-13 | - |
dc.date.issued | 2023-06 | - |
dc.identifier.issn | 1661-6596 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/113642 | - |
dc.description.abstract | This study aimed to synthesize 23 coumarin derivatives and analyze their anti-inflammatory effects on lipopolysaccharide (LPS)-induced inflammation in RAW264.7 macrophages. A cytotoxicity test performed on LPS-induced RAW264.7 macrophages revealed that none of the 23 coumarin derivatives were cytotoxic. Among the 23 coumarin derivatives, coumarin derivative 2 showed the highest anti-inflammatory activity by significantly reducing nitric oxide production in a concentration-dependent manner. Coumarin derivative 2 inhibited the production of proinflammatory cytokines, including tumor necrosis factor alpha and interleukin-6, and decreased the expression level of each mRNA. In addition, it inhibited the phosphorylation of extracellular signal-regulated kinase, p38, c-Jun NH2-terminal kinase, nuclear factor kappa-B p65 (NF-& kappa;B p65), and inducible nitric oxide synthase. These results indicated that coumarin derivative 2 inhibited LPS-induced mitogen-activated protein kinase and NF-& kappa;B p65 signal transduction pathways in RAW264.7 cells, as well as proinflammatory cytokines and enzymes related to inflammatory responses, to exert anti-inflammatory effects. Coumarin derivative 2 showed potential for further development as an anti-inflammatory drug for the treatment of acute and chronic inflammatory diseases. | - |
dc.language | English | - |
dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | - |
dc.title | Synthesis and Biological Properties of Pyranocoumarin Derivatives as Potent Anti-Inflammatory Agents | - |
dc.type | Article | - |
dc.identifier.doi | 10.3390/ijms241210026 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | International Journal of Molecular Sciences, v.24, no.12 | - |
dc.citation.title | International Journal of Molecular Sciences | - |
dc.citation.volume | 24 | - |
dc.citation.number | 12 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 001017267900001 | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | NF-KAPPA-B | - |
dc.subject.keywordPlus | SELECTIVE ACETYLCHOLINESTERASE INHIBITORS | - |
dc.subject.keywordPlus | NITRIC-OXIDE | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | INFLAMMATION | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordPlus | TRANSCRIPTION | - |
dc.subject.keywordPlus | ARISUGACIN | - |
dc.subject.keywordPlus | DISEASES | - |
dc.subject.keywordAuthor | Coumarins | - |
dc.subject.keywordAuthor | RAW264 | - |
dc.subject.keywordAuthor | 7 macrophages | - |
dc.subject.keywordAuthor | lipopolysaccharide | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.